Skip to content
HOME Insights

Brochure: Trusted iPSC Solutions for Toxicology

As a pioneer in iPSC technology, Ncardia provides products and screening services for preclinical safety pharmacology and toxicity studies at high-throughput.
DOWNLOAD NOW
toxicology brochure

Discover Ncardia's Platforms for Toxicology Studies

Minimize risk of late-stage failures by incorporating iPSC models earlier in your pipeline. Whether you need to detect cardiotoxicity, neurotoxicity or evaluate early safety, we have developed robust platforms to help you.
Topics
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the document by filling out the form below: